
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
Around September 20, 2022, Jupiter Neurosciences announced it was postponing its plans to have an IPO on the Nasdaq. Here's what we know about the IPO so far and how to buy Jupiter Neurosciences stock.
On October 12, 2021, Jupiter Neurosciences—a Florida-based pharmaceutical company that primarily develops neuro-inflammation treatments—filed a prospectus with the US Securities and Exchange Commission (SEC) to go public. You can view a more current version of the document here.
It had planned to offer 29.5 million stocks on the Nasdaq Capital Market under the ticker symbol "JUNS." Altogether, Jupiter Neurosciences had hoped to raise around $15 million from the IPO. Stocks were expected to begin trading around September 20, 2022.
Shortly before this, Jupiter Neurosciences announced it was postponing the IPO. "Market conditions" have been cited as the reason for the postponement.
The company has not announced a future IPO date. We'll update this page as more information becomes available.
Once Jupiter Neurosciences goes public, you'll need a brokerage account to invest. Consider opening a brokerage account today so you're ready as soon as the stock hits the market.
It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. Looking at the performance of similar companies can help you decide if now is a good time to buy Jupiter Neurosciences stock.
See how the following stocks are performing, and view details like market capitalization, the price-to-earnings (P/E) ratio, price/earnings-to-growth (PEG) ratio and dividend yield.The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
A simple guide to buying stocks in your favorite European soccer team.
Read more…Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Read more…We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Read more…